awjourn
-
Today on Xconomy: Halo raises $1.1M from 12 patient groups to advance its muscular dystrophy drug
6:12 AM May 24th
via TweetDeck
-
Today on Xconomy: Can Keryx get out of the Wall Street penalty box after the failure of its colon cancer drug?
5:50 AM May 22nd
via TweetDeck
-
Today on Xconomy: How Prize4Life is applying a prize-based model to finding new weapons against Lou Gehrig's disease
5:51 AM May 17th
via TweetDeck
-
Today on Xconomy NYC: Lenddo grabs $8M to expand loans to emerging countries, and 5 Q's for Ernst & Young on health IT
6:18 AM May 15th
via TweetDeck
-
RT @: Congratulations to Xconomy's @, a finalist for a 2012 Gerald Loeb Award
9:32 AM May 14th
via TweetDeck
-
New Tech City: Has NYC surpassed Boston in the rankings of leading tech hubs? Check out the latest at Xconomy
5:52 AM May 11th
via TweetDeck
-
Today on Xconomy: Jumptap, Mobtext, and Razorfish talk about the future of mobile advertising:
6:17 AM May 10th
via TweetDeck
-
Today on Xconomy: 60-year-old Cancer Research Institute ventures into venture philanthropy
5:51 AM May 9th
via TweetDeck
-
Retrophin, headed by controversial hedge fund chief Martin Shkreli, closes $4M funding round, today on Xconomy:
9:41 AM May 7th
via TweetDeck
-
Style mavens on fashion tech 2.0: It's about having great products, not technology, today on Xconomy
7:59 AM May 7th
via TweetDeck
-
Today on Xconomy: Cloud file-sharing provider Box looks to NYC, Seattle and Boston for innovation
6:00 AM May 3rd
via TweetDeck
-
Today on Xconomy NYC: Fed-up doc creates app to improve doctor-patient communications
6:17 AM May 2nd
via TweetDeck
-
The robots are coming! It's our photo/video gallery of Silicon Valley's coolest bots:
6:56 AM Apr 26th
via TweetDeck
-
RT @: 'Selling the Fountain of Youth: How the Anti-Aging Industry Made a Disease Out of Getting Old'
7:00 AM Apr 26th
via TweetDeck
-
Today on Xconomy: Epizyme gets $90M in epigenetics collaboration with Celgene
6:58 AM Apr 26th
via TweetDeck
-
Today on Xconomy: What's it like to be a cash-strapped biotech developing a diabetes drug? Not easy
6:48 AM Apr 25th
via TweetDeck
-
Today on Xconomy: Material Wrld, seeded at Harvard Business School, is a peer-to-peer market for used clothing
7:51 AM Apr 23rd
via TweetDeck
-
Today on Xconomy: Does progress for Pervasis and InVivo signal a revival of regenerative medicine?
7:57 AM Apr 19th
via TweetDeck
-
Today on Xconomy: How Pipeline Fellowship is grooming female angel investors and entrepreneurs
7:49 AM Apr 18th
via TweetDeck
-
Check out Xconomy's review of the new book by Gilt Group founders @ and @
12:10 PM Apr 17th
via TweetDeck
|
- Name Arlene Weintraub
- Web http://www.arlene...
- Bio I am a biotech editor and writer for Xconomy.com, and the author of Selling the Fountain of Youth (more at www.sellingthefountainofyouth.com)
|